Topics and Expertise: drug dosing

Data-driven drug dosing speeds tuberculosis treatment to four months

Mon Aug 30, 2021
bacterial cells
NIAID/NIH

Mycobacterium tuberculosis, the cause of tuberculosis

A large trial of a new drug regimen for tuberculosis, designed in part by School researchers, leads to a new WHO recommendation for treating the disease.

Research points to individualized treatments for curing TB

Tue Nov 20, 2018
Savic speaking at podium

Rada Savic, PhD, senior author on the study, presented her team's work on tuberculosis treatments at the 49th Union World Conference on Lung Health in The Hague, The Netherlands, in late October 2018.

Tuberculosis is usually treated with a six month regimen of daily antibiotics, but millions of patients do not recover from the disease during treatment. Rada Savic’s team showed that adjusting the duration of this regimen based on disease severity could lead to better outcomes.

New NIH funding awarded to the Department of Clinical Pharmacy in 2011

Fri Apr 13, 2012
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy: